Results 91 to 100 of about 41,221 (142)

Extended Interval Dosing of Aminoglycosides in Renal Transplant Patients

Open Forum Infectious Diseases, 2015
Arnold Decano, Tiffany Bias, Alden Doyle, Gregory Malat   +3 more
openaire   +1 more source

Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing. [PDF]

Neurology, 2019
Ryerson LZ, Foley J, Chang I, Kister I, Cutter G, Metzger RR, Goldberg JD, Li X, Riddle E, Smirnakis K, Kasliwal R, Ren Z, Hotermans C, Ho PR, Campbell N.   +14 more
europepmc   +1 more source

Pharmacodynamics of a Long-Acting Echinocandin, CD101, in a Neutropenic Invasive-Candidiasis Murine Model Using an Extended-Interval Dosing Design. [PDF]

Antimicrob Agents Chemother, 2018
Lepak AJ, Zhao M, VanScoy B, Ambrose PG, Andes DR.   +4 more
europepmc   +1 more source

Efficacy of Extended-Interval Dosing of Micafungin Evaluated Using a Pharmacokinetic/Pharmacodynamic Study with Humanized Doses in Mice. [PDF]

Antimicrob Agents Chemother, 2016
Lepak A, Marchillo K, VanHecker J, Azie N, Andes D.   +4 more
europepmc   +1 more source

Extended interval dosing of natalizumab: is efficacy preserved?

, 2018
Clerico, M, Signori, A, De Mercanti, S, Cordioli, C, Signoriello, E, Lus, G, Maniscalco, GT, Curti, E, Lorefice, L, Cocco, E, Nociti, V, Mirabella, M, Baroncini, D, Landi, D, Mataluni, G, Petruzzo, M, Lanzillo, R, Gandoglia, I, Laroni, A, Frangiamore, R, Sartori, A, Cavalla, P, Costantini, G, Sormani, MP, Capra, R   +24 more
openaire   +1 more source

Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine [PDF]

Cell, 2021
Extension of the interval between vaccine doses for the BNT162b2 mRNA vaccine was introduced in the United Kingdom to accelerate population coverage with a single dose. At this time, trial data were lacking, and we addressed this in a study of United Kingdom healthcare workers.
Stephanie Longet, David Eyre, Susan Hopkins   +2 more
exaly   +6 more sources

Some of the next articles are maybe not open access.

Related searches:

Efficacy and safety of natalizumab extended interval dosing

Multiple Sclerosis and Related Disorders, 2018
It is postulated that extending the dosing interval of natalizumab (NTZ) from 4 to 5-8 weeks might decrease the risk of progressive multifocal leukoencephalopathy (PML). The aim of this study was to assess the effect of extended interval dosing (EID) on the therapeutic efficacy of natalizumab.We reviewed 85 patients treated at two MS centers in the ...
Hani Tamim, Bassem Yamout, Mohammad Ali Sahraian   +2 more
exaly   +3 more sources

Extended interval dosing with ocrelizumab in multiple sclerosis [PDF]

Multiple Sclerosis Journal
Background: This study investigates clinical and biomarker differences between standard interval dosing (SID) and extended interval dosing (EID) of ocrelizumab therapy in multiple sclerosis (MS). Methods: This is a prospective, double ...
Frederik Novak, Inga Urbonaviciute
exaly   +7 more sources

Extended-interval Aminoglycoside Dosing in Pediatrics

Pediatric Infectious Disease Journal, 2011
Aminoglycosides (AGs) are often used in combination with -lactam antibiotics for the treatment of serious Gram-negative infections. Traditionally, AGs have been dosed multiple times a day. Over the past decade, extended-interval dosing has been evaluated as a method of improving the efficacy and safety of AGs.
Alice M, Jenh, Pranita D, Tamma, Aaron M, Milstone   +2 more
openaire   +2 more sources